Leptin brain entry via a tanycytic LepR-EGFR shuttle controls lipid metabolism and pancreas function.
Journal
Nature metabolism
ISSN: 2522-5812
Titre abrégé: Nat Metab
Pays: Germany
ID NLM: 101736592
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
12
11
2019
accepted:
23
06
2021
pubmed:
4
8
2021
medline:
5
10
2021
entrez:
3
8
2021
Statut:
ppublish
Résumé
Metabolic health depends on the brain's ability to control food intake and nutrient use versus storage, processes that require peripheral signals such as the adipocyte-derived hormone, leptin, to cross brain barriers and mobilize regulatory circuits. We have previously shown that hypothalamic tanycytes shuttle leptin into the brain to reach target neurons. Here, using multiple complementary models, we show that tanycytes express functional leptin receptor (LepR), respond to leptin by triggering Ca
Identifiants
pubmed: 34341568
doi: 10.1038/s42255-021-00432-5
pii: 10.1038/s42255-021-00432-5
pmc: PMC7611554
mid: EMS128607
doi:
Substances chimiques
Leptin
0
Receptors, Leptin
0
ErbB Receptors
EC 2.7.10.1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1071-1090Subventions
Organisme : NIDDK NIH HHS
ID : R01 DK123002
Pays : United States
Organisme : European Research Council
ID : 810331
Pays : International
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Swinburn, B. A. et al. The global syndemic of obesity, undernutrition, and climate change: The Lancet Commission Report. Lancet 393, 791–846 (2019).
doi: 10.1016/S0140-6736(18)32822-8
Yoon, K. H. et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 368, 1681–1688 (2006).
pubmed: 17098087
doi: 10.1016/S0140-6736(06)69703-1
Ohn, J. H. et al. 10-year trajectory of beta-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study. Lancet Diabetes Endocrinol. 4, 27–34 (2016).
pubmed: 26577716
doi: 10.1016/S2213-8587(15)00336-8
Ahima, R. S. & Flier, J. S. Leptin. Annu. Rev. Physiol. 62, 413–437 (2000).
pubmed: 10845097
doi: 10.1146/annurev.physiol.62.1.413
de Luca, C. et al. Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes. J. Clin. Invest. 115, 3484–3493 (2005).
pubmed: 16284652
pmcid: 1280964
doi: 10.1172/JCI24059
Cohen, P. et al. Selective deletion of leptin receptor in neurons leads to obesity. J. Clin. Invest 108, 1113–1121 (2001).
pubmed: 11602618
pmcid: 209535
doi: 10.1172/JCI200113914
Caron, A., Lee, S., Elmquist, J. K. & Gautron, L. Leptin and brain-adipose crosstalks. Nat. Rev. Neurosci. 19, 153–165 (2018).
pubmed: 29449715
pmcid: 5962962
doi: 10.1038/nrn.2018.7
Pan, W. W. & Myers, M. G. Jr. Leptin and the maintenance of elevated body weight. Nat. Rev. Neurosci. 19, 95–105 (2018).
pubmed: 29321684
doi: 10.1038/nrn.2017.168
Friedman, J. M. Leptin and the endocrine control of energy balance. Nat. Metab. 1, 754–764 (2019).
pubmed: 32694767
doi: 10.1038/s42255-019-0095-y
Kamohara, S., Burcelin, R., Halaas, J. L., Friedman, J. M. & Charron, M. J. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389, 374–377 (1997).
pubmed: 9311777
doi: 10.1038/38717
Coppari, R. et al. The hypothalamic arcuate nucleus: a key site for mediating leptin’s effects on glucose homeostasis and locomotor activity. Cell Metab. 1, 63–72 (2005).
pubmed: 16054045
doi: 10.1016/j.cmet.2004.12.004
Buettner, C. et al. Critical role of STAT3 in leptin’s metabolic actions. Cell Metab. 4, 49–60 (2006).
pubmed: 16814732
pmcid: 3638026
doi: 10.1016/j.cmet.2006.04.014
Buettner, C. et al. Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms. Nat. Med. 14, 667–675 (2008).
pubmed: 18516053
pmcid: 2671848
doi: 10.1038/nm1775
Prevot, V. et al. The versatile tanycyte: a hypothalamic integrator of reproduction and energy metabolism. Endocr. Rev. 39, 333–368 (2018).
pubmed: 29351662
doi: 10.1210/er.2017-00235
Garcia-Caceres, C. et al. Role of astrocytes, microglia, and tanycytes in brain control of systemic metabolism. Nat. Neurosci. 22, 7–14 (2019).
pubmed: 30531847
doi: 10.1038/s41593-018-0286-y
Banks, W. A. The blood–brain barrier as an endocrine tissue. Nat. Rev. Endocrinol. 15, 444–455 (2019).
pubmed: 31127254
doi: 10.1038/s41574-019-0213-7
Schaeffer, M. et al. Rapid sensing of circulating ghrelin by hypothalamic appetite-modifying neurons. Proc. Natl Acad. Sci. USA 110, 1512–1517 (2013).
pubmed: 23297228
pmcid: 3557016
doi: 10.1073/pnas.1212137110
Ciofi, P. et al. Brain-endocrine interactions: a microvascular route in the mediobasal hypothalamus. Endocrinology 150, 5509–5519 (2009).
pubmed: 19837874
pmcid: 2819742
doi: 10.1210/en.2009-0584
Yulyaningsih, E. et al. Acute lesioning and rapid repair of hypothalamic neurons outside the blood–brain barrier. Cell Rep. 19, 2257–2271 (2017).
pubmed: 28614713
pmcid: 5651178
doi: 10.1016/j.celrep.2017.05.060
Djogo, T. et al. Adult NG2-glia are required for median eminence-mediated leptin sensing and body weight control. Cell Metab. 23, 797–810 (2016).
pubmed: 27166944
doi: 10.1016/j.cmet.2016.04.013
Mullier, A., Bouret, S. G., Prevot, V. & Dehouck, B. Differential distribution of tight junction proteins suggests a role for tanycytes in blood–hypothalamus barrier regulation in the adult mouse brain. J. Comp. Neurol. 518, 943–962 (2010).
pubmed: 20127760
pmcid: 2892518
doi: 10.1002/cne.22273
Langlet, F. et al. Tanycytic VEGF-A boosts blood–hypothalamus barrier plasticity and access of metabolic signals to the arcuate nucleus in response to fasting. Cell Metab. 17, 607–617 (2013).
pubmed: 23562080
pmcid: 3695242
doi: 10.1016/j.cmet.2013.03.004
Balland, E. et al. Hypothalamic tanycytes are an ERK-gated conduit for leptin into the brain. Cell Metab. 19, 293–301 (2014).
pubmed: 24506870
pmcid: 3936883
doi: 10.1016/j.cmet.2013.12.015
Yuan, X., Caron, A., Wu, H. & Gautron, L. Leptin receptor expression in mouse intracranial perivascular cells. Front. Neuroanat. 12, 4 (2018).
pubmed: 29410615
pmcid: 5787097
doi: 10.3389/fnana.2018.00004
Yoo, S., Cha, D., Kim, D. W., Hoang, T. V. & Blackshaw, S. Tanycyte-independent control of hypothalamic leptin signaling. Front. Neurosci. 13, 240 (2019).
pubmed: 30941008
pmcid: 6433882
doi: 10.3389/fnins.2019.00240
Bhaskar, V. et al. An allosteric antibody to the leptin receptor reduces body weight and reverses the diabetic phenotype in the Lep(ob) /Lep(ob) mouse. Obesity (Silver Spring) 24, 1687–1694 (2016).
doi: 10.1002/oby.21539
Jo, Y. H., Chen, Y. J., Chua, S. C. Jr., Talmage, D. A. & Role, L. W. Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron 48, 1055–1066 (2005).
pubmed: 16364907
pmcid: 2280039
doi: 10.1016/j.neuron.2005.10.021
Irani, B. G., Le Foll, C., Dunn-Meynell, A. & Levin, B. E. Effects of leptin on rat ventromedial hypothalamic neurons. Endocrinology 149, 5146–5154 (2008).
pubmed: 18556346
pmcid: 2582924
doi: 10.1210/en.2008-0357
Kusumakshi, S. et al. A binary genetic approach to characterize TRPM5 cells in mice. Chem. Senses 40, 413–425 (2015).
pubmed: 25940069
doi: 10.1093/chemse/bjv023
Niv-Spector, L. et al. Identification of the hydrophobic strand in the A–B loop of leptin as major binding site III: implications for large-scale preparation of potent recombinant human and ovine leptin antagonists. Biochem. J. 391, 221–230 (2005).
pubmed: 15952938
pmcid: 1276919
doi: 10.1042/BJ20050457
Muller-Fielitz, H. et al. Tanycytes control the hormonal output of the hypothalamic-pituitary-thyroid axis. Nat. Commun. 8, 484 (2017).
pubmed: 28883467
pmcid: 5589884
doi: 10.1038/s41467-017-00604-6
Frayling, C., Britton, R. & Dale, N. ATP-mediated glucosensing by hypothalamic tanycytes. J. Physiol. 589, 2275–2286 (2011).
pubmed: 21486800
pmcid: 3098703
doi: 10.1113/jphysiol.2010.202051
Auriau, J. et al. Gain of affinity for VEGF165 binding within the VEGFR2/NRP1 cellular complex detected by an HTRF-based binding assay. Biochem. Pharmacol. 158, 45–59 (2018).
pubmed: 30236477
doi: 10.1016/j.bcp.2018.09.014
Vauthier, V. et al. Design and validation of a homogeneous time-resolved fluorescence-based leptin receptor binding assay. Anal. Biochem. 436, 1–9 (2013).
pubmed: 23333588
doi: 10.1016/j.ab.2012.12.013
Langlet, F., Mullier, A., Bouret, S. G., Prevot, V. & Dehouck, B. Tanycyte-like cells form a blood-cerebrospinal fluid barrier in the circumventricular organs of the mouse brain. J. Comp. Neurol. 521, 3389–3405 (2013).
pubmed: 23649873
pmcid: 3973970
doi: 10.1002/cne.23355
Howard, J. K. & Flier, J. S. Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol. Metab. 17, 365–371 (2006).
pubmed: 17010638
doi: 10.1016/j.tem.2006.09.007
Chmielewski, A. et al. Preclinical assessment of leptin transport into the cerebrospinal fluid in diet-induced obese minipigs. Obesity (Silver Spring) 27, 950–956 (2019).
doi: 10.1002/oby.22465
Balland, E., Chen, W., Tiganis, T. & Cowley, M. A. Persistent leptin signalling in the arcuate nucleus impairs hypothalamic insulin signalling and glucose homeostasis in obese mice. Neuroendocrinology 109, 374–390 (2019).
pubmed: 30995667
doi: 10.1159/000500201
Sukumaran, S., Xue, B., Jusko, W. J., Dubois, D. C. & Almon, R. R. Circadian variations in gene expression in rat abdominal adipose tissue and relationship to physiology. Physiol. Genomics 42A, 141–152 (2010).
pubmed: 20682845
pmcid: 2957797
doi: 10.1152/physiolgenomics.00106.2010
Tschop, M., Smiley, D. L. & Heiman, M. L. Ghrelin induces adiposity in rodents. Nature 407, 908–913 (2000).
pubmed: 11057670
doi: 10.1038/35038090
Schwartz, M. W. et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45, 531–535 (1996).
pubmed: 8603777
doi: 10.2337/diab.45.4.531
Pelleymounter, M. A. et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269, 540–543 (1995).
pubmed: 7624776
doi: 10.1126/science.7624776
Berglund, E. D. et al. Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice. J. Clin. Invest. 122, 1000–1009 (2012).
pubmed: 22326958
pmcid: 3287225
doi: 10.1172/JCI59816
Back, S. H. & Kaufman, R. J. Endoplasmic reticulum stress and type 2 diabetes. Annu. Rev. Biochem. 81, 767–793 (2012).
pubmed: 22443930
pmcid: 3684428
doi: 10.1146/annurev-biochem-072909-095555
Sohn, J. W. et al. Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons. Cell 152, 612–619 (2013).
pubmed: 23374353
pmcid: 3711728
doi: 10.1016/j.cell.2012.12.022
Muzumdar, R. et al. Physiologic effect of leptin on insulin secretion is mediated mainly through central mechanisms. FASEB J. 17, 1130–1132 (2003).
pubmed: 12709405
doi: 10.1096/fj.02-0991fje
Fagerholm, V., Haaparanta, M. & Scheinin, M. Alpha2-adrenoceptor regulation of blood glucose homeostasis. Basic Clin. Pharmacol. Toxicol. 108, 365–370 (2011).
pubmed: 21418144
doi: 10.1111/j.1742-7843.2011.00699.x
Rosengren, A. H. et al. Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes. Science 327, 217–220 (2010).
pubmed: 19965390
doi: 10.1126/science.1176827
Wang, P. et al. A leptin-BDNF pathway regulating sympathetic innervation of adipose tissue. Nature 583, 839–844 (2020).
pubmed: 32699414
doi: 10.1038/s41586-020-2527-y
Ahima, R. S. et al. Role of leptin in the neuroendocrine response to fasting. Nature 382, 250–252 (1996).
pubmed: 8717038
doi: 10.1038/382250a0
Zhou, Y. et al. Temporal dynamic reorganization of 3D chromatin architecture in hormone-induced breast cancer and endocrine resistance. Nat. Commun. 10, 1522 (2019).
pubmed: 30944316
pmcid: 6447566
doi: 10.1038/s41467-019-09320-9
Liu, Z. et al. Short-term tamoxifen treatment has long-term effects on metabolism in high-fat diet-fed mice with involvement of Nmnat2 in POMC neurons. FEBS Lett. 592, 3305–3316 (2018).
pubmed: 30192985
doi: 10.1002/1873-3468.13240
Shida, D., Kitayama, J., Mori, K., Watanabe, T. & Nagawa, H. Transactivation of epidermal growth factor receptor is involved in leptin-induced activation of janus-activated kinase 2 and extracellular signal-regulated kinase 1/2 in human gastric cancer cells. Cancer Res. 65, 9159–9163 (2005).
pubmed: 16230373
doi: 10.1158/0008-5472.CAN-05-0598
Prevot, V., Cornea, A., Mungenast, A., Smiley, G. & Ojeda, S. R. Activation of erbB-1 signaling in tanycytes of the median eminence stimulates transforming growth factor beta1 release via prostaglandin E2 production and induces cell plasticity. J. Neurosci. 23, 10622–10632 (2003).
pubmed: 14627647
pmcid: 6740908
doi: 10.1523/JNEUROSCI.23-33-10622.2003
Lomniczi, A., Cornea, A., Costa, M. E. & Ojeda, S. R. Hypothalamic tumor necrosis factor-alpha converting enzyme mediates excitatory amino acid-dependent neuron-to-glia signaling in the neuroendocrine brain. J. Neurosci. 26, 51–62 (2006).
pubmed: 16399672
pmcid: 6674310
doi: 10.1523/JNEUROSCI.2939-05.2006
Balthasar, N. et al. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 42, 983–991 (2004).
pubmed: 15207242
doi: 10.1016/j.neuron.2004.06.004
van de Wall, E. et al. Collective and individual functions of leptin receptor modulated neurons controlling metabolism and ingestion. Endocrinology 149, 1773–1785 (2008).
pubmed: 18162515
doi: 10.1210/en.2007-1132
Vauthier, V. et al. Endospanin1 affects oppositely body weight regulation and glucose homeostasis by differentially regulating central leptin signaling. Mol. Metab. 6, 159–172 (2017).
pubmed: 28123946
doi: 10.1016/j.molmet.2016.10.009
Obici, S. et al. Central melanocortin receptors regulate insulin action. J. Clin. Invest. 108, 1079–1085 (2001).
pubmed: 11581309
pmcid: 200952
doi: 10.1172/JCI200112954
Fan, W. et al. The central melanocortin system can directly regulate serum insulin levels. Endocrinology 141, 3072–3079 (2000).
pubmed: 10965876
doi: 10.1210/endo.141.9.7665
Rossi, J. et al. Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis. Cell Metab. 13, 195–204 (2011).
pubmed: 21284986
pmcid: 3033043
doi: 10.1016/j.cmet.2011.01.010
Coppari, R. & Bjorbaek, C. Leptin revisited: its mechanism of action and potential for treating diabetes. Nat. Rev. Drug Discov. 11, 692–708 (2012).
pubmed: 22935803
pmcid: 4019022
doi: 10.1038/nrd3757
Colberg, S. R., Simoneau, J. A., Thaete, F. L. & Kelley, D. E. Skeletal muscle utilization of free fatty acids in women with visceral obesity. J. Clin. Invest. 95, 1846–1853 (1995).
pubmed: 7706491
pmcid: 295723
doi: 10.1172/JCI117864
Beaufrere, B. & Morio, B. Fat and protein redistribution with aging: metabolic considerations. Eur. J. Clin. Nutr. 54, S48–S53 (2000).
pubmed: 11041075
doi: 10.1038/sj.ejcn.1601025
Zamboni, M., Mazzali, G., Fantin, F., Rossi, A. & Di Francesco, V. Sarcopenic obesity: a new category of obesity in the elderly. Nutr. Metab. Cardiovasc. Dis. 18, 388–395 (2008).
pubmed: 18395429
doi: 10.1016/j.numecd.2007.10.002
Parr, E. B., Coffey, V. G. & Hawley, J. A. ‘Sarcobesity’: a metabolic conundrum. Maturitas 74, 109–113 (2013).
pubmed: 23201324
doi: 10.1016/j.maturitas.2012.10.014
Tian, S. & Xu, Y. Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies. Geriatr. Gerontol. Int. 16, 155–166 (2016).
pubmed: 26271226
doi: 10.1111/ggi.12579
Okun, J. G. et al. Liver alanine catabolism promotes skeletal muscle atrophy and hyperglycaemia in type 2 diabetes. Nat. Metab. 3, 394–409 (2021).
pubmed: 33758419
doi: 10.1038/s42255-021-00369-9
Prentki, M. & Nolan, C. J. Islet beta cell failure in type 2 diabetes. J. Clin. Invest. 116, 1802–1812 (2006).
pubmed: 16823478
pmcid: 1483155
doi: 10.1172/JCI29103
Steil, G. M. et al. Adaptation of beta-cell mass to substrate oversupply: enhanced function with normal gene expression. Am. J. Physiol. Endocrinol. Metab. 280, E788–E796 (2001).
pubmed: 11287362
doi: 10.1152/ajpendo.2001.280.5.E788
Tuomi, T. et al. The many faces of diabetes: a disease with increasing heterogeneity. Lancet 383, 1084–1094 (2014).
pubmed: 24315621
doi: 10.1016/S0140-6736(13)62219-9
Morimoto, A. et al. Impact of impaired insulin secretion and insulin resistance on the incidence of type 2 diabetes mellitus in a Japanese population: the Saku study. Diabetologia 56, 1671–1679 (2013).
pubmed: 23680915
doi: 10.1007/s00125-013-2932-y
Peitz, M., Pfannkuche, K., Rajewsky, K. & Edenhofer, F. Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc. Natl Acad. Sci. USA 99, 4489–4494 (2002).
pubmed: 11904364
pmcid: 123675
doi: 10.1073/pnas.032068699
Folgueira, C. et al. Hypothalamic dopamine signaling regulates brown fat thermogenesis. Nat. Metab. 1, 811–829 (2019).
pubmed: 31579887
pmcid: 6774781
doi: 10.1038/s42255-019-0099-7
Quinones, M. et al. Sirt3 in POMC neurons controls energy balance in a sex- and diet-dependent manner. Redox Biol. 41, 101945 (2021).
pubmed: 33744652
pmcid: 8005845
doi: 10.1016/j.redox.2021.101945
Bruss, M. D., Khambatta, C. F., Ruby, M. A., Aggarwal, I. & Hellerstein, M. K. Calorie restriction increases fatty acid synthesis and whole body fat oxidation rates. Am. J. Physiol. Endocrinol. Metab. 298, E108–E116 (2010).
pubmed: 19887594
doi: 10.1152/ajpendo.00524.2009
Imbernon, M. et al. Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic/JNK1 pathways. Gastroenterology 144, 636–649 (2013).
pubmed: 23142626
doi: 10.1053/j.gastro.2012.10.051
Nogueiras, R. et al. The central melanocortin system directly controls peripheral lipid metabolism. J. Clin. Invest. 117, 3475–3488 (2007).
pubmed: 17885689
pmcid: 1978426
doi: 10.1172/JCI31743
Golde, W. T., Gollobin, P. & Rodriguez, L. L. A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab. Anim. 34, 39–43 (2005).
doi: 10.1038/laban1005-39
Clasadonte, J., Scemes, E., Wang, Z., Boison, D. & Haydon, P. G. Connexin 43-mediated astroglial metabolic networks contribute to the regulation of the sleep–wake cycle. Neuron 95, 1365–1380 (2017).
pubmed: 28867552
pmcid: 5617118
doi: 10.1016/j.neuron.2017.08.022
Bouret, S. G., Bates, S. H., Chen, S., Myers, M. G. & Simerly, R. B. Distinct roles for specific leptin receptor signals in the development of hypothalamic feeding circuits. J. Neurosci. 32, 1244–1252 (2012).
pubmed: 22279209
pmcid: 3567460
doi: 10.1523/JNEUROSCI.2277-11.2012
Annicotte, J. S. et al. The CDK4-pRB-E2F1 pathway controls insulin secretion. Nat. Cell Biol. 11, 1017–1023 (2009).
pubmed: 19597485
pmcid: 2824657
doi: 10.1038/ncb1915
Blanchet, E. et al. E2F transcription factor-1 regulates oxidative metabolism. Nat. Cell Biol. 13, 1146–1152 (2011).
pubmed: 21841792
doi: 10.1038/ncb2309
de Seranno, S. et al. Role of estradiol in the dynamic control of tanycyte plasticity mediated by vascular endothelial cells in the median eminence. Endocrinology 151, 1760–1772 (2010).
pubmed: 20133455
pmcid: 2850227
doi: 10.1210/en.2009-0870
Rabhi, N. et al. Cdkn2a deficiency promotes adipose tissue browning. Mol. Metab. 8, 65–76 (2018).
pubmed: 29237539
doi: 10.1016/j.molmet.2017.11.012
Dhillon, S. S. & Belsham, D. D. Leptin differentially regulates NPY secretion in hypothalamic cell lines through distinct intracellular signal transduction pathways. Regul. Pept. 167, 192–200 (2011).
pubmed: 21262273
doi: 10.1016/j.regpep.2011.01.005
Zabeau, L. et al. Selection of non-competitive leptin antagonists using a random nanobody-based approach. Biochem. J. 441, 425–434 (2012).
pubmed: 21851341
doi: 10.1042/BJ20110438
Student. The probable error of a mean. Biometrika 6, 1–25 (1908).
Fay, D. S. & Gerow, K. A biologist’s guide to statistical thinking and analysis. Wormbook http://www.wormbook.org/chapters/www_statisticalanalysis/statisticalanalysis.html (2013).
Charan, J. & Biswas, T. How to calculate sample size for different study designs in medical research? Indian J. Psychol. Med. 35, 121–126 (2013).
pubmed: 24049221
pmcid: 3775042
doi: 10.4103/0253-7176.116232